Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions-Reference-Cited by-同舟云学术

Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions

Published:2009-08 Issue:4 Volume:2 Page:339-347
ISSN:1941-7640
Container-title:Circulation: Cardiovascular Interventions
language:en
Short-container-title:Circ Cardiovasc Interv

Author:

Claessen Bimmer E.¹,Beijk Marcel A.¹,Legrand Victor¹,Ruzyllo Witold¹,Manari Antonio¹,Varenne Olivier¹,Suttorp Maarten J.¹,Tijssen Jan G.P.¹,Miquel-Hebert Karine¹,Veldhof Susan¹,Henriques Jose P.S.¹,Serruys Patrick W.¹,Piek Jan J.¹

Affiliation:

1. From the Department of Cardiology (B.E.C., M.A.B., J.G.P.T., J.P.S.H., J.J.P.), Academic Medical Center, University of Amsterdam, The Netherlands; C.H.U. de Liege Sart Tilman (V.L.), Liege, Belgium; National Institute of Cardiology in Warsaw (W.R.), Warsaw, Poland; Azienda Ospedaliera Santa Maria Nuova (A.M.), Reggio Emilia, Italy; Hopital Cochin (O.V.), Paris, France; St. Antonius Ziekenhuis (M.J.S.), Nieuwegein, The Netherlands; Abbott Vascular (K.M.-H., S.V.), Diegem, Belgium; and Thoraxcenter (P...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Coronary Artery Stents

2. Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents

3. Two-year results of a durable polymer everolimus-eluting stent in de novo coronary artery stenosis (The SPIRIT FIRST Trial)

4. Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium everolimus-eluting stents in patients with coronary artery disease: Rationale and design of the IRONMAN-II trial;American Heart Journal;2024-09

2. Comparative effectiveness of ultrathin vs. standard strut drug-eluting stents: insights from a large-scale meta-analysis with extended follow-up;European Journal of Medical Research;2024-07-27

3. Comparative Effectiveness of Ultrathin vs. Standard Strut Drug-Eluting Stents: Insights from a Large-Scale Meta-Analysis with Extended Follow-up;2024-04-01

4. First-in-human evaluation of a novel ultrathin sirolimus- eluting iron bioresorbable scaffold: 3-year outcomes of the IBS-FIM trial;EUROINTERVENTION;2023

5. Durable Polymer Everolimus Eluting Stents;Interventional Cardiology;2022-05-06